Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1996
09/17/1996US5556981 Angiotensin II antagonist intermediates
09/17/1996US5556953 Dna sequence with code, genetic engineering
09/17/1996US5556947 Monoclonal antibody recognizing a surface molecule on a subset of antigen-stimulated T cells and on certain malignancies of T and B cell origin
09/17/1996US5556945 Tumor suppressor gene
09/17/1996US5556943 Cell adhesion protein, gene coding for the same, process for preparing the same and carrier onto which the same is immobilized
09/17/1996US5556942 Glutathione S-transferase-activated compounds
09/17/1996US5556941 Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
09/17/1996US5556940 Parathyroid hormone analogues for the treatment of osteoporosis
09/17/1996US5556939 TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
09/17/1996US5556837 Methods for treating addictive disorders
09/17/1996US5556836 Use of D-glucopyranuronic acids and their derivatives for incorporation in pharmacologically active peptides and their salts
09/17/1996US5556782 Transformed mammalian cells capable of expressing cecropin b
09/17/1996US5556781 DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses
09/17/1996US5556767 Polynucleotide encoding macrophage inflammatory protein γ
09/17/1996US5556766 Method of producing LYS-plasminogen
09/17/1996US5556763 Patterns of transcription factors and lymphocytes
09/17/1996US5556762 Scanning synthetic peptide combinatorial libraries: oligopeptide mixture sets having a one predetermined residue at a single, predetermined position, methods of making and using the same
09/17/1996US5556757 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their CNS carrier and uses thereof
09/17/1996US5556755 Oligonucleotides and dna sequences
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/17/1996US5556645 Methods of enhancing wound healing and tissue repair
09/17/1996US5556621 Heat and acid resistant polypeptides or proteins as antiinflammatory agents
09/17/1996US5556620 Colony stimulating factor for skin healing
09/17/1996US5556609 Metal labled peptides for medical diagnosis of diseases
09/16/1996CA2171509A1 Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment
09/14/1996CA2171600A1 Dna molecules
09/12/1996WO1996027672A1 Latency active herpes virus promoters and their use to treat neurological lesions
09/12/1996WO1996027666A1 Novel avian cytokines and genetic sequences encoding same
09/12/1996WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
09/12/1996WO1996027663A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
09/12/1996WO1996027657A1 Cell growth substrates with tethered cell growth effector molecules
09/12/1996WO1996027613A1 Mono- and polyclonal antibodies against e2 protein region 63-75
09/12/1996WO1996027611A1 A method for identifying a novel multidrug-resistance type
09/12/1996WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
09/12/1996WO1996027608A1 Process for producing a protein
09/12/1996WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/12/1996WO1996027393A1 A dry powder formulation for gene therapy
09/12/1996WO1996027392A1 Antigen presenting system and methods for activation of t-cells
09/12/1996WO1996027390A1 Compositions and methods for stimulating antibody class switching
09/12/1996WO1996027389A1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
09/12/1996WO1996027388A1 Stabilized compositions containing hemoglobin
09/12/1996WO1996027387A1 Identification of self and non-self antigens implicated in autoimmune disease
09/12/1996WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
09/12/1996WO1996027385A1 Anti-obesity proteins
09/12/1996WO1996027381A1 Immunosuppressive agents
09/12/1996WO1996027380A1 Reduction of infarct volume using citicoline
09/12/1996WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8
09/12/1996WO1996027370A1 Free radical scavenger molecules
09/12/1996WO1996027369A2 Compositions for the treatment of blood disorders
09/12/1996WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996WO1996021733A3 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy
09/12/1996WO1996021468A3 Chemically modified interferon
09/12/1996WO1996021028A3 Soluble heterodimeric t cell receptors and their antibodies
09/12/1996WO1996021016A3 New staphylokinase derivatives
09/12/1996WO1996020950A3 Compositions and methods for treating rheumatoid arthritis
09/12/1996WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
09/12/1996WO1996016079A3 Alpha-ketoamide derivatives as cathepsin l inhibitor
09/12/1996WO1996003502A3 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer
09/12/1996DE19513659A1 Microparticle formulations of aggregation-sensitive polypeptides
09/12/1996DE19508672A1 Cyclic parathyroid hormone fragments with lactam bridge
09/12/1996CA2214726A1 Compositions and methods for stimulating antibody class switching
09/12/1996CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996CA2214453A1 Novel avian cytokines and genetic sequences encoding same
09/12/1996CA2214379A1 Compositions for the treatment of blood disorders
09/12/1996CA2214283A1 Anti-obesity proteins
09/12/1996CA2213000A1 Reduction of infarct volume using citicoline
09/12/1996CA2212125A1 Process for producing a protein
09/12/1996CA2189738A1 Identification of self and non-self antigens implicated in autoimmune disease
09/11/1996EP0731168A1 MSRV-1 virus and pathogenic and/or infectious agent MSRV-2 associated with rheumatoid arthritis
09/11/1996EP0731167A1 Modular assembly of antibody genes, antibodies prepared thereby and use
09/11/1996EP0731164A1 HUMAN PHOSPHOLIPASE C-$g(a) AND DNA SEQUENCE CODING FOR THE SAME
09/11/1996EP0731110A1 Methods for the production of conformationally stabilized cell adhesion peptides
09/11/1996EP0731109A1 Purification of D-factor
09/11/1996EP0731108A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes
09/11/1996EP0731106A1 Novel peptide derivative
09/11/1996EP0731088A2 Retroviral protease inhibitors
09/11/1996EP0730869A1 Biodegradable medicinal polymer assembly with supermolecular structure
09/11/1996EP0730868A1 Formulated medicines for treatment of oral inflammation, and processed foods to treat and prevent stomatitis
09/11/1996EP0730740A1 Kinase receptor activation assay
09/11/1996EP0730661A1 Compounds with pth activity and recombinant dna vectors encoding same
09/11/1996EP0730660A1 Chimeric proteins including protease nexin-1 variants
09/11/1996EP0730657A1 Composition for the in vivo production of therapeutic products
09/11/1996EP0730651A1 Surface loop structural analogues of fibroblast growth factors
09/11/1996EP0730650A1 Retroviral superantigens, superantigen peptides, and methods of use
09/11/1996EP0730649A1 Mutated hig-e fragments and derivative thereof
09/11/1996EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
09/11/1996EP0730647A1 Dna sequence coding for a bmp receptor
09/11/1996EP0730646A1 PROTEIN TYROSINE KINASES NAMED Rse
09/11/1996EP0730609A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
09/11/1996EP0730608A1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
09/11/1996EP0730607A1 Novel integrin-binding peptides
09/11/1996EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
09/11/1996EP0730605A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
09/11/1996EP0730604A1 Surface membrane proteins and their effect on immune response
09/11/1996EP0730601A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
09/11/1996EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
09/11/1996EP0730578A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
09/11/1996EP0730473A1 Hirudin conjugates from hirudin and lipophilic compounds
1 ... 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 ... 3163